(Q39997379)

16 September 2017

title

Inducible BRAF suppression models for melanoma tumorigenesis (English)

1 reference

16 September 2017

Klaus P Hoeflich

1

1 reference

16 September 2017

Bijay Jaiswal

series ordinal

2

1 reference

16 September 2017

David P Davis

series ordinal

3

1 reference

16 September 2017

Somasekar Seshagiri

series ordinal

4

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

16 September 2017

published in

Methods in Enzymology

1 reference

16 September 2017

volume

439

1 reference

16 September 2017

page(s)

25-38

1 reference

CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

New insight into BRAF mutations in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Targeting RAS signalling pathways in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

pHUSH: a single vector system for conditional gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Melanoma biology and new targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Control of expression of the Tn10-encoded tetracycline resistance operon II. Interaction of RNA polymerase and TET repressor with the tet operon regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Oncogenic BRAF is required for tumor growth and maintenance in melanoma models

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Imaging tri-fusion multimodality reporter gene expression in living subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

The RAF proteins take centre stage

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

V599EB-RAF is an oncogene in melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

Mutations of the BRAF gene in benign and malignant melanocytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900403-X

7 January 2021

10.1016/S0076-6879(07)00403-X

Identifiers

DOI

1 reference

16 September 2017

1 reference